Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation.

MLA

Carey, Steven S., et al. “Outcomes for Children with Recurrent/Refractory Atypical Teratoid Rhabdoid Tumor: A Single‐institution Study with Molecular Correlation.” Pediatric Blood & Cancer, vol. 71, no. 10, Oct. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1002/pbc.31208.

APA

Carey, S. S., Huang, J., Myers, J. R., Mostafavi, R., Orr, B. A., Dhanda, S. K., Michalik, L. H., Tatevossian, R. G., Klimo, P., Boop, F., Lu, C., Sioson, E., Zhou, X., Nichols, K. E., Merchant, T. E., Ellison, D. W., Robinson, G. W., Onar, T. A., Gajjar, A., & Upadhyaya, S. A. (2024). Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation. Pediatric Blood & Cancer, 71(10), 1–10. https://doi.org/10.1002/pbc.31208

Chicago

Carey, Steven S., Jie Huang, Jason R. Myers, Roya Mostafavi, Brent A. Orr, Sandeep Kumar Dhanda, Layna H. Michalik, et al. 2024. “Outcomes for Children with Recurrent/Refractory Atypical Teratoid Rhabdoid Tumor: A Single‐institution Study with Molecular Correlation.” Pediatric Blood & Cancer 71 (10): 1–10. doi:10.1002/pbc.31208.